F-1186-2019 Class II Terminated

Recalled by ProThera, Inc. Dba SFI USA — Reno, NV

FDA food recall F-1186-2019 was initiated by ProThera, Inc. Dba SFI USA on Dec 13, 2018 and is designated Class II. Reason for recall: Mis-packaging; product is labeled as Reduce L-Glutathione but actually contains Lithium Orotate. The recall status is terminated (terminated Apr 2, 2019). Affected quantity: 139 bottles.

Recall details

Product Type
Food
Report Date
Apr 3, 2019
Initiation Date
Dec 13, 2018
Termination Date
Apr 2, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
139 bottles

Product description

Klaire Labs Reduced L-Glutathione 150 mg capsules, single capsule dose 100 vegetarian capsules SKU V799-10 UPC Code: 7 09616 79910 9

Reason for recall

Mis-packaging; product is labeled as Reduce L-Glutathione but actually contains Lithium Orotate.

Distribution pattern

US distribution to the following: AL, AZ, CA, KS, LA, MI, MO, NH, NJ, NY, OR, PA, TX, and WA Foreign distribution to the following: Netherlands, Great Britain, and Korea

Code information

FG Lot: 2018210303 Expiration: 05/2020

Source

Dataset
openFDA food recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for F-1186-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 15, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for F-1186-2019. Report a data issue: hello@regdatalab.com.